Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

Peter M Calverley1 Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UKCorrespondence[email protected]

Göran Eriksson2 Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden

Christine R Jenkins3 George Institute for Global Health, The University of Sydney and Concord Clinical School, Sydney, Australia

Antonio R Anzueto4 Department of Pulmonary Medicine and Allergology, University of Texas Health Sciences Center and South Texas Veterans’ Health Care System, San Antonio, Texas

Barry J Make5 Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, Colorado, USA

Anders Persson6 AstraZeneca R&D, Gothenburg, Sweden

Malin Fagerås6 AstraZeneca R&D, Gothenburg, Sweden

Dirkje S Postma7 Department of Pulmonary Medicine and Tuberculosis, GRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

show all

Pages 13-25 | Published online: 19 Dec 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MurrayCRichardsMNewtonJUK health performance: findings of the Global Burden of Disease Study 2010Lancet20133819871997102023668584
PubMed Web of Science ®Google Scholar
YangGWangYZengYRapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010Lancet201338198821987201523746901
PubMed Web of Science ®Google Scholar
CalverleyPAndersonJCelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
PubMed Web of Science ®Google Scholar
TashkinDCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
PubMed Web of Science ®Google Scholar
De SoyzaACalverleyPMALarge trials, new knowledge: the changing face of COPD managementEur Respir J20154561692170325792640
PubMed Web of Science ®Google Scholar
Global Initiative for Chronic Obstructive Lung Disease (GOLD)From the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Updated 2016 Available from: http://www.goldcopd.org/2016Accessed January 2016
Google Scholar
WiseRAAnzuetoACottonDTiotropium Respimat inhaler and the risk of death in COPDN Engl JMed2013369161491150123992515
PubMed Web of Science ®Google Scholar
VestboJPauwelsRAndersonJJonesPCalverleyPTRISTSAN GroupEarly onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary diseaseThorax200560430130415790985
PubMed Web of Science ®Google Scholar
SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
PubMed Web of Science ®Google Scholar
WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
PubMed Web of Science ®Google Scholar
JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
PubMed Web of Science ®Google Scholar
CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur RespirJ200322691291914680078
PubMed Web of Science ®Google Scholar
RennardSTashkinDMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs200969554956519368417
PubMed Web of Science ®Google Scholar
TashkinDRennardSMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trialDrugs200868141975200018778120
PubMed Web of Science ®Google Scholar
SharafkhanehASouthardJGoldmanMUryniakTMartinUEffect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized studyRespir Med2012106225726822033040
PubMed Web of Science ®Google Scholar
CalverleyPMSpencerSWillitsLBurgePSJonesPWWithdrawal from treatment as an outcome in the ISOLDE study of COPDChest200312441350135614555565
PubMed Web of Science ®Google Scholar
AlbertPAgustiAEdwardsLBronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseaseThorax201267870170822696176
PubMed Web of Science ®Google Scholar
DellacàRPompilioPWalkerPDuffyNPedottiACalverleyPEffect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPDEur Respir J20093361329133719164347
PubMed Web of Science ®Google Scholar
JenkinsCRPostmaDSAnzuetoARReliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary diseaseBMC Pulm Med2015159726293575
PubMed Web of Science ®Google Scholar
FukuchiYSamoroRFassakhovRBudesonide/formoterol via Turbuhaler(R) versus formoterol via Turbuhaler(R) in patients with moderate to severe chronic obstructive pulmonary disease: phase III multinational study resultsRespirology201318586687323551359
PubMed Web of Science ®Google Scholar
CalverleyPPauwels DaggerRLofdahlCGRelationship between respiratory symptoms and medical treatment in exacerbations of COPDEur Respir J200526340641316135720
PubMed Web of Science ®Google Scholar
LeidyNWilcoxTJonesPStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
PubMed Web of Science ®Google Scholar
JonesPBrusselleGDal NegroRProperties of the COPD assessment test in a cross-sectional European studyEur Respir J2011381293521565915
PubMed Web of Science ®Google Scholar
WedzichaJDecramerMFickerJAnalysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group studyLancet Respir Med20131319920924429126
PubMed Web of Science ®Google Scholar
WiltTJNiewoehnerDMacDonaldRKaneRLManagement of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guidelineAnn Intern Med2007147963965317975187
PubMed Web of Science ®Google Scholar
CalverleyPMAlbertPWalkerPPBronchodilator reversibility in chronic obstructive pulmonary disease: use and limitationsLancet20131756457324461617
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date